Portland, OR, June 23, 2022 (GLOBE NEWSWIRE) — According to the report published by Allied Market Research, the global Intravenous (IV) Therapy And Vein Access Market generated $22.8 billion in 2020, and is projected to reach $37.5 billion by 2030, growing at a CAGR of 5.1% from 2021 to 2030. The report provides an in-depth analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive scenario, and wavering market trends.
Download Sample PDF at: https://www.alliedmarketresearch.com/request-sample/2350
Significant surge in the cases of chronic diseases among people, growth in road accidents, increase in healthcare expenditure and healthcare insurance, and increase in geriatric population across the globe are expected to drive the growth of the global intravenous (IV) therapy and vein access market. On the other hand, lack of experienced healthcare professionals is expected to hinder the growth of the market. However, remarkable upsurge in critical care therapies is expected to create ample opportunities for the industry.
COVID-19 Scenario
- The outbreak of COVID-19 has had a positive impact on the growth of the global intravenous (IV) therapy and vein access market, owing to the rapid increase in the spread of coronavirus among people across the globe. IV therapy was extensively used among patients suffering from severe COVID-19-associated acute respiratory distress syndrome (ARDS).
- Thus, increase in…
